Publicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (16)

2020

  1. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

    European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270

2018

  1. Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients

    Infection and Immunity, Vol. 86, Núm. 12

2017

  1. Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes

    Thrombosis and Haemostasis, Vol. 117, Núm. 1, pp. 66-74

  2. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

    International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516

2016

  1. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders

    Haemophilia, Vol. 22, Núm. 4, pp. 590-597

  2. Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

    European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302

2015

  1. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

    American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43

2013

  1. Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia

    European Journal of Haematology, Vol. 91, Núm. 3, pp. 236-241

2010

  1. Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction-Angiographic and intravascular ultrasound-Results from the TErapia Celular Aplicada al Miocardio Pilot study

    American Heart Journal, Vol. 159, Núm. 6, pp. 1154.e1-1154.e8

2009

  1. Comparison of Neointimal Hyperplasia With Drug-Eluting Stents Versus Bare Metal Stents in Patients Undergoing Intracoronary Bone-Marrow Mononuclear Cell Transplantation Following Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 103, Núm. 12, pp. 1651-1656

2008

  1. Impacto de la obstrucción microvascular persistente en el remodelado ventricular postinfarto tras el implante intracoronario de células mononucleadas de médula ósea: Un estudio de cardiorresonancia con contraste

    Revista Espanola de Cardiologia, Vol. 61, Núm. 6, pp. 602-610

2005

  1. Psychometric field study of the new haemophilia quality of life questionnaire for adults: The 'Hemofilia-QoL'

    Haemophilia, Vol. 11, Núm. 6, pp. 603-610

2004

  1. Bone remodelation markers are useful in the management of monoclonal gammopathies

    Hematology Journal, Vol. 5, Núm. 6, pp. 480-488

  2. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction

    Circulation Research, Vol. 95, Núm. 7, pp. 742-748

  3. Intracoronary stem cell transplantation in acute myocardial infarction

    Revista Espanola de Cardiologia, Vol. 57, Núm. 3, pp. 201-208

2003

  1. Immunophenotypic analysis of Waldenstrom's macroglobulinemia

    Seminars in Oncology, Vol. 30, Núm. 2, pp. 187-195